A Pilot Randomized Controlled Trial of Homeopathic Treatment for Long COVID

NCT07694232 | Not Yet Recruiting DMC

• 1 other identifier: Fibert P 01
• Study Type: interventional
• Target: 120
• Locations: 1 country
• Sites: 1

Brief Summary

A small-scale test of the intervention, trial design and methods to explore the cumulative effectiveness of two commonly used prescribing strategies for patients with long COVID: Treatment A - prescribing a specific homeopathic remedy for long COVID, plus or minus Treatment B - a course of individually tailored treatment by a homeopath. Both interventions compared to usual care

Conditions

Long COVID; Long COVID Symptoms

Keywords

homeopathy; long COVID; randomised controlled trial

Outcome Measures

Primary Outcomes (1)

• Measure Your Own Medical Outcome Profile (MYMOP)

  The participant chooses two symptoms that bother them the most. They also choose an activity of daily living that is limited or prevented by their problem. These choices are written down in the patient's own words and the patient scores them for severity over the past week on a seven-point scale.

  monthly for 6 months

Secondary Outcomes (1)

• Wellbeing Health Survey Questionnaire (SF-36)

  monthly for 6 months

Study Arms (3)

Treatment A

ACTIVE COMPARATOR

treatment by a homeopath prescribing a specific homeopathic remedy for long COVID

Other: Treatment A: Treatment by a homeopath prescribing a specific homeopathic remedy for long COVID

Treatment B

ACTIVE COMPARATOR

A course of individually tailored treatment by a homeopath consisting of up to four homeopathic consultations one month apart, and individually tailored homeopathic remedies

Other: a course of individually tailored treatment by a homeopath

Usual care cohort

NO INTERVENTION

Interventions

Treatment A: Treatment by a homeopath prescribing a specific homeopathic remedy for long COVID OTHER

prescription of a specific homeopathic remedy for long COVID

Treatment A

a course of individually tailored treatment by a homeopath OTHER

A series of up to four consultations with a homeopath, one month apart, and at the end of each consultation the homeopath prescribes an individually tailored homeopathic remedy

Treatment B

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Adults who experienced acute COVID-19 at least 12 weeks ago
• A medical diagnosis of long COVID (diagnosis by a healthcare professional, documentation from an NHS long COVID clinic, or equivalent formal medical verification)
• At least one recognized long COVID symptom according to NHS criteria
• Agreement to be contacted again and interest in participating in research.

You may not qualify if:

• Those who have not had acute COVID-19
• Those who have not received a medical diagnosis of long COVID
• Those not currently experiencing symptoms (MYMOP average score 1 or less)
• Inability to give informed consent
• Inability to complete online forms and receive zoom calls
• Those currently under homeopathic treatment
• Those who have started a new medication or treatment for long COVID within the past month
• Those suffering from life threatening conditions

Sponsors & Collaborators

• St. Mary's University, Twickenham: lead
• Institute for Ethical Research Governance: collaborator
• Homeopathy International: collaborator

Study Sites (1)

St Mary's University

London, Buckinghamshire, TW1 4SX, United Kingdom

Location

MeSH Terms

Conditions

Post-Acute COVID-19 Syndrome

Condition Hierarchy (Ancestors)

COVID-19; Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases; Post-Infectious Disorders; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Clare Relton, PhD

  Queen Mary University of London

  STUDY CHAIR

Central Study Contacts

Philippa Fibert, PhD, MSc, B.Ed, B.Sc

CONTACT

+447543345046; philippa.fibert@stmarys.ac.uk

Vinita Pandey

CONTACT

vinitapandey@hotmail.co.uk

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SEQUENTIAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate lecturer

Model Details: Participants are recruited to an observational cohort. They are then randomised to either remain in the cohort, or to the intervention arm. The Intervention arm is further randomised to continue with the initial treatment, or to receive an adjunctive treatment

Study Record Dates

• First Submitted: July 2, 2026
• First Posted: July 9, 2026
• Study Start: July 15, 2026
• Primary Completion (Estimated): July 1, 2028
• Study Completion (Estimated): December 1, 2028
• Last Updated: July 9, 2026

Record last verified: 2026-07

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL, CSR
• Time Frame: Once the collection period has been completed the data will be exported and stored on St Mary's University servers securely for a period of 10 years.
• Access Criteria: Once anonymised, data (but not free-text responses) may be made available to researchers on request

Locations

GB (1)